Heidi Evidence vs The Monday Clinical Brief: Pull vs Push for UK Clinicians

Heidi Evidence launched in February 2026 and immediately changed the conversation for UK clinicians. It has a free tier. It is powered by Claude. It is partnered with NICE and BMJ Group. It gives you cited, UK-relevant clinical answers in seconds.

If you are a UK doctor wondering whether Heidi Evidence replaces your need for a journal digest subscription, the honest answer is: no. But the reason is not that Heidi is bad. It is that Heidi and a weekly digest do fundamentally different jobs.

June 2026 update: The UK position is unchanged in substance, but two things have firmed up. BMJ Group is now a named Heidi Evidence content partner, with a dedicated UK page — so Evidence answers draw on BMJ Group content alongside NICE and HealthPathways. And Heidi's paid tiers are now public: Evidence Plus runs at about $30 per user per month (~$360/year), the cheapest paid Evidence tier — against £20/year for a full MCB subscription. Access for UK clinicians is still limited, but the limit is specific: Heidi documents Evidence as available to UK and EU users only outside live patient sessions. In-session evidence querying is disabled under current compliance settings, so Heidi cannot answer during the consultation itself. This is specific to the Evidence feature: Heidi Scribe, the AI clinical documentation tool, is separately MHRA-cleared and remains available to UK clinicians. Heidi Evidence has now passed roughly 2 million queries globally — the category economics are proven; the in-session door is the part that is still shut for UK and EU users. See our explainer on Heidi Evidence's UK and EU restrictions for the detail and what UK clinicians can use in the meantime.

The Core Difference: Pull vs Push

Heidi Evidence is a pull tool. You have a clinical question. You type it in. It retrieves an answer grounded in authoritative sources — NICE guidelines, BMJ Group content, HealthPathways, MIMS, and others. The answer arrives with citations you can check.

A weekly journal digest is a push tool. Every Monday morning, it tells you what was published last week across the top journals in your specialty. You did not ask. You did not know to ask. The digest surfaces what is new before you have a patient in front of you who makes the question urgent.

This distinction matters because the two tools protect against different kinds of ignorance.

Heidi protects against not knowing the answer when a question arises. It is a safety net at the point of care. A patient presents with an unfamiliar drug interaction. You ask Heidi. You get a cited answer. Good.

A digest protects against not knowing the question exists. A landmark trial published last Tuesday changes the evidence base for a treatment you prescribe weekly. If you do not read about it, you will never think to ask Heidi. You will continue prescribing the old way, not because the evidence is unavailable, but because you do not know it has changed.

The first kind of ignorance is reactive. The second is structural. Both matter.

What Heidi Evidence Does Well

Credit where it is due. Heidi Evidence is a strong product and a useful one for UK clinicians.

UK-specific sources. The partnership with NICE and BMJ Group means answers reflect UK guidelines, not FDA recommendations or American clinical pathways. For UK GPs especially, this is a meaningful advantage over US-centric tools like UpToDate or OpenEvidence.

A free base tier. The base tier costs nothing, and in a market where UpToDate charges hundreds of pounds and NEJM Clinician charges £75, that matters. Heidi has since added paid tiers — Evidence Plus at roughly $360 a year is the cheapest — but the entry point is still free.

Integrated with the Heidi platform. If you already use Heidi as an AI scribe for clinical documentation, Evidence sits inside the same interface. No context switching.

MHRA-adjacent credibility. Through the AutoMedica acquisition, Heidi has a regulatory signal via the MHRA AI Airlock pilot. For institutions evaluating clinical AI tools, this matters.

Ad-free, and built on Claude. Heidi Evidence carries no advertising and is ISO 42001 audited — its answers are not shaped by who is paying. We have run on the same principle since launch, and MCB is also Claude-summarised. On posture, the two products agree: no ads, no algorithmic feed deciding what you see. The difference is the job, not the values — Heidi answers the question you bring; the digest brings you the questions you did not know to ask.

What Heidi Evidence Cannot Do

Heidi retrieves answers to questions you ask. It does not tell you what you should have asked this week.

This is not a criticism. It is a design choice. Heidi is built for the consultation room, not for Monday morning reading. It excels at reactive evidence lookup. It is not built to provide:

Systematic weekly coverage. There is no "show me everything published in palliative care last week" feature. Heidi responds to queries, not calendars.

Structured CPD output. A weekly digest formatted for CPD logging — with reflection prompts, time tracking, and citations formatted for your appraisal portfolio — is not what Heidi is built to do. You can log Heidi lookups manually, but the product does not prompt or structure it.

Serendipitous discovery. The most valuable thing a digest does is show you a paper you would never have searched for. A cross-specialty finding, a trial in a neighbouring field, a methodology paper that changes how you interpret evidence in your own domain. Pull tools, by definition, cannot surface what you have not thought to look for.

Reading habit formation. Doctors who maintain a fixed weekly reading habit produce more consistent CPD portfolios than those who read reactively. Heidi supports reactive reading. A digest supports habitual reading. The habit is what keeps you current; the lookup is what keeps you safe.

The Practical Combination

For most UK doctors, the best setup is not either/or. It is both.

Monday morning: read the digest. Fifteen minutes. See what was published last week. Catch the trials, guidelines, and systematic reviews you would have missed. Log it for CPD.

During the week: use Heidi. A patient presents with something unfamiliar. A colleague asks a question you cannot answer from memory. You check Heidi. You get a cited, UK-relevant answer in seconds.

If you need evidence lookup during a live consultation: Heidi Evidence's in-session mode is restricted for UK and EU users, so it answers only outside the consultation. iatroX is a credible UK alternative for point-of-care clinical Q&A — MHRA-registered, UKCA-marked, and built around UK guideline retrieval. The pull-vs-push argument in this post applies the same way: combine iatroX (or another pull tool) with a weekly digest, and you cover both kinds of gap. We have no commercial relationship with iatroX — we mention it because it is an option a UK reader can use in the moment.

The digest feeds your general awareness. The pull tool — whichever one is currently available to you — handles the specific gaps. One is preventive; the other is acute. You need both for the same reason you need both a screening programme and an emergency department.

Who Should Choose One Over the Other

If you genuinely have to pick one — perhaps you are an F1 with no budget — pick Heidi Evidence. It is free, it is useful at the point of care, and it is better than nothing.

If you have £20 a year and fifteen minutes a week, add a digest. The investment is negligible. The return — in CPD evidence, in awareness, in not being blindsided by a guideline change — is disproportionate.

If you are a GP, generalist, or portfolio clinician covering multiple areas, the digest is arguably more important than the lookup tool. Your job requires breadth. You cannot query Heidi for papers you do not know exist. You need the push.

How MCB Fits Alongside Heidi

The Monday Clinical Brief is built for the push role. Every Monday, you get the top papers from the five highest-impact journals in your specialty — summarised, reflection-prompted, and formatted for CPD. Thirty-one specialties. £20 a year.

Heidi Evidence is an excellent consultation-room companion. MCB is the Monday morning companion. Use Heidi when you need an answer. Use MCB to make sure you know the questions.

Start your four-week trial and pair it with Heidi for full coverage — push and pull, weekly and on-demand, current awareness and point-of-care.